[go: up one dir, main page]

CN101843829B - Chinese medicament for treating pulmonary heart diseases - Google Patents

Chinese medicament for treating pulmonary heart diseases Download PDF

Info

Publication number
CN101843829B
CN101843829B CN2009102383040A CN200910238304A CN101843829B CN 101843829 B CN101843829 B CN 101843829B CN 2009102383040 A CN2009102383040 A CN 2009102383040A CN 200910238304 A CN200910238304 A CN 200910238304A CN 101843829 B CN101843829 B CN 101843829B
Authority
CN
China
Prior art keywords
chinese
chinese medicine
pulmonary heart
chinese medicament
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102383040A
Other languages
Chinese (zh)
Other versions
CN101843829A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102383040A priority Critical patent/CN101843829B/en
Publication of CN101843829A publication Critical patent/CN101843829A/en
Application granted granted Critical
Publication of CN101843829B publication Critical patent/CN101843829B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating pulmonary heart diseases and belongs to the field of Chinese medicaments for treating respiratory diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: snakegourd fruit, Chinese angelica, loguat leaf, fritillaria, tangerine peel, radix pseudo-ginseng, root of rehmannia, lucid ganoderma and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, clearing lung and eliminating phlegm, and depurating lung and relieving asthma, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for the treatment of pulmonary heart disease
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
The existing Chinese medicine aspect that is used for the treatment of pulmonary heart disease, the deficiency that has two aspects: the one, therapeutic effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of patients with cor pulmonale are subsisted in uncomfortable in chest, cardiopalmus, dyspnea for a long time, edema of lower limbs, cough is breathed hard, and can not alleviate for many years, and patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of pulmonary heart disease, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of pulmonary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Fructus Trichosanthis 4-30 part Radix Angelicae Sinensis 4-30 part Folium Eriobotryae 3-20 part
Bulbus Fritillariae Uninbracteatae 4-30 part Pericarpium Citri Reticulatae 3-20 part Radix Notoginseng 3-20 part
Radix Rehmanniae 4-30 part Ganoderma 2-12 part
The Chinese medicine of this treatment pulmonary heart disease is made by following method:
(1) by above-mentioned weight ratio, Fructus Trichosanthis, Radix Angelicae Sinensis, Folium Eriobotryae, Bulbus Fritillariae Uninbracteatae, Pericarpium Citri Reticulatae, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, tranquilizing by nourishing the heart, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng passage, nourishing blood, blood circulation promoting and blood stasis dispelling is strengthened cardiopulmonary and is organized microcirculation; Be aided with Fructus Trichosanthis, Bulbus Fritillariae Uninbracteatae removing heat from the lung and dissipating phlegm; Pericarpium Citri Reticulatae is regulated the flow of vital energy to dredge and is stagnated; The respectful lung of Folium Eriobotryae is relievingd asthma.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, removing heat from the lung and dissipating phlegm, the merit that respectful lung is relievingd asthma, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Fructus Trichosanthis 80 gram Radix Angelicae Sinensis 80 gram Folium Eriobotryaes 60 grams
Bulbus Fritillariae Uninbracteatae 80 gram Pericarpium Citri Reticulataes 60 gram Radix Notoginseng 60 grams
The Radix Rehmanniae 80 kairine sesames 40 grams
Weight in accordance with regulations, with conventional water extraction process Fructus Trichosanthis, Radix Angelicae Sinensis, Folium Eriobotryae, Bulbus Fritillariae Uninbracteatae, Pericarpium Citri Reticulatae, the Radix Rehmanniae are extracted, make extractum fine powder 132 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 828 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Fructus Trichosanthis 160 gram Radix Angelicae Sinensis 160 gram Folium Eriobotryaes 120 grams
Bulbus Fritillariae Uninbracteatae 160 gram Pericarpium Citri Reticulataes 120 gram Radix Notoginseng 120 grams
The Radix Rehmanniae 160 kairine sesames 60 grams
By above-mentioned same method, make 1585 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Fructus Trichosanthis 300 gram Radix Angelicae Sinensis 300 gram Folium Eriobotryaes 200 grams
Bulbus Fritillariae Uninbracteatae 300 gram Pericarpium Citri Reticulataes 200 gram Radix Notoginseng 200 grams
The Radix Rehmanniae 300 kairine sesames 120 grams
By above-mentioned same method, make 2857 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
4 parts of 7 parts of Folium Eriobotryaes of 7 parts of Radix Angelicae Sinensis of Fructus Trichosanthis
4 parts of 4 portions of Radix Notoginseng of 7 parts of Pericarpium Citri Reticulataes of Bulbus Fritillariae Uninbracteatae
3 parts of 7 portions of Ganodermas of the Radix Rehmanniae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
12 parts of 20 parts of Folium Eriobotryaes of 20 parts of Radix Angelicae Sinensis of Fructus Trichosanthis
12 parts of 12 portions of Radix Notoginseng of 20 parts of Pericarpium Citri Reticulataes of Bulbus Fritillariae Uninbracteatae
8 parts of 20 portions of Ganodermas of the Radix Rehmanniae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science pulmonary heart disease, through 9 routine clinical observations.Selecting the tcm diagnosis pulmonary heart disease is standard: have a delicate constitution, and limb adynamia, feeling of oppression and pain in the chest, cough is breathed hard, dyspnea, edema of lower limbs.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 6 examples, women's 3 examples do not have other serious disease, and the age is 57 years old-79 years old, 67.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, symptoms such as feeling of oppression and pain in the chest, dyspnea are obviously alleviated.
2, effective: body constitution strengthens, and symptoms such as feeling of oppression and pain in the chest, dyspnea are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.9 philtrums of clinical experiment, produce effects 4 people, effective 4 people, invalid 1 people, total effective rate 88.8%.

Claims (1)

1. a Chinese medicine for the treatment of pulmonary heart disease adopts the raw material of Chinese medicine preparation, it is characterized in that it is to make with the component of following weight ratio:
Fructus Trichosanthis 4-30 part Radix Angelicae Sinensis 4-30 part Folium Eriobotryae 3-20 part
Bulbus Fritillariae Uninbracteatae 4-30 part Pericarpium Citri Reticulatae 3-20 part Radix Notoginseng 3-20 part
Radix Rehmanniae 4-30 part Ganoderma 2-12 part
The Chinese medicine of this treatment pulmonary heart disease is made by following method:
(1) by above-mentioned weight ratio, Fructus Trichosanthis, Radix Angelicae Sinensis, Folium Eriobotryae, Bulbus Fritillariae Uninbracteatae, Pericarpium Citri Reticulatae, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102383040A 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases Expired - Fee Related CN101843829B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102383040A CN101843829B (en) 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102383040A CN101843829B (en) 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases

Publications (2)

Publication Number Publication Date
CN101843829A CN101843829A (en) 2010-09-29
CN101843829B true CN101843829B (en) 2011-06-29

Family

ID=42768767

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102383040A Expired - Fee Related CN101843829B (en) 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases

Country Status (1)

Country Link
CN (1) CN101843829B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435794A (en) * 2014-09-23 2015-03-25 牛欣青 Electuary for treating chronic pulmonary heart disease and preparation method thereof
CN105288193A (en) * 2015-11-25 2016-02-03 李涛 Yin nourishing and heat clearing preparation for treating pulmonary heart diseases, and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537068A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating angina
CN101537114A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating arrhythmia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537068A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating angina
CN101537114A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating arrhythmia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
冷建春.益气活血法在肺心病剂型发作期的临床应用.《中西医结合心脑血管病杂志》.2004,第2卷(第10期), *
才晓茹等.中医药为主治疗肺心病心力衰竭的临床研究进展.《中西医结合心脑血管病杂志》.2005,第3卷(第9期), *

Also Published As

Publication number Publication date
CN101843829A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN101843712B (en) Chinese medicament for treating angina
CN101884762B (en) Traditional Chinese medicine for treating emphysema
CN101850017B (en) Chinese medicament for treating asthma
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843717B (en) Chinese medicament for treating coronary disease
CN101897847B (en) Traditional Chinese medicine for curing asthma
CN101537068B (en) Chinese medicine for treating angina
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101850079B (en) Chinese medicament for treating asthma
CN101843729B (en) Chinese medicament for treating cervical spondylosis
CN101850083B (en) Chinese medicament for treating asthma
CN101843793B (en) Chinese medicament for treating tachycardia
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843758B (en) Chinese medicament for treating coronary disease
CN101843719A (en) Chinese medicament for treating pulmonary heart diseases
CN101879246A (en) Traditional Chinese medicine for treating lupus erythematosus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130701

Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166.

Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110629

Termination date: 20151118